Lisdexamfetamine for the Treatment of Severe Obesity in Children Aged 6 to 12 Years
Latest Information Update: 24 Nov 2024
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 20 Nov 2023 Planned initiation date changed from 1 Nov 2023 to 20 Nov 2023.
- 20 Nov 2023 Status changed from not yet recruiting to recruiting.
- 02 Oct 2023 Planned End Date changed from 30 Jun 2029 to 30 Nov 2029.